Dopamine transporter binding in the brain is linked to irritable bowel syndrome in Parkinson's disease

Gastrointestinal symptoms are common in Parkinson's disease (PD), but their neurophysiological correlates are not well understood. We recently reported that functional gastrointestinal symptoms were not associated with asymmetry per se but might be associated with lower left striatal dopamine transporter (DAT) binding. The purpose of this study was to further investigate if specific gastrointestinal symptoms associate with monoamine transporter changes in specific striatal or extrastriatal areas.

[1]  F. Scheperjans,et al.  Diagnostic value of micrographia in Parkinson’s disease: a study with [123I]FP-CIT SPECT , 2022, Journal of Neural Transmission.

[2]  E. Pekkonen,et al.  Gastrointestinal Symptoms and Dopamine Transporter Asymmetry in Early Parkinson's Disease , 2022, Movement disorders : official journal of the Movement Disorder Society.

[3]  A. Lundervold,et al.  Gut bless you: The microbiota-gut-brain axis in irritable bowel syndrome , 2022, World journal of gastroenterology.

[4]  F. Scheperjans,et al.  Environmental triggers of Parkinson's disease – Implications of the Braak and dual-hit hypotheses , 2021, Neurobiology of Disease.

[5]  Sen Lu,et al.  Association between irritable bowel syndrome and Parkinson's disease: A systematic review and meta‐analysis , 2021, Acta neurologica Scandinavica.

[6]  Y. Yang,et al.  Association Between Irritable Bowel Syndrome and Risk of Parkinson's Disease: A Systematic Review and Meta-Analysis , 2021, Frontiers in Neurology.

[7]  R. Parkkola,et al.  Sex correction improves the accuracy of clinical dopamine transporter imaging , 2021, EJNMMI Research.

[8]  Jonathan P. Jacobs,et al.  A bidirectional relationship between anxiety, depression and gastrointestinal symptoms in Parkinson’s disease , 2021, Clinical parkinsonism & related disorders.

[9]  Hong-ming Zhu,et al.  Study on the characteristics of intestinal motility of constipation in patients with Parkinson's disease , 2021, World journal of gastroenterology.

[10]  P. Borghammer.  The α-Synuclein Origin and Connectome Model (SOC Model) of Parkinson’s Disease: Explaining Motor Asymmetry, Non-Motor Phenotypes, and Cognitive Decline , 2021, Journal of Parkinson's disease.

[11]  A. Sjölander,et al.  Irritable bowel syndrome and Parkinson’s disease risk: register-based studies , 2021, NPJ Parkinson's disease.

[12]  H. Berendse,et al.  Autonomic failure in Parkinson’s disease is associated with striatal dopamine deficiencies , 2020, Journal of Neurology.

[13]  V. Garibotto,et al.  Extrastriatal 123I-FP-CIT SPECT impairment in Parkinson’s disease – the PPMI cohort , 2020, BMC Neurology.

[14]  D. Perani,et al.  Extrastriatal dopaminergic and serotonergic pathways in Parkinson’s disease and in dementia with Lewy bodies: a 123I-FP-CIT SPECT study , 2019, European Journal of Nuclear Medicine and Molecular Imaging.

[15]  H. Berendse,et al.  Striatal DAT and extrastriatal SERT binding in early-stage Parkinson's disease and dementia with Lewy bodies, compared with healthy controls: An 123I-FP-CIT SPECT study , 2019, NeuroImage: Clinical.

[16]  R. Kim,et al.  Association of autonomic symptoms with presynaptic striatal dopamine depletion in drug-naive Parkinson's disease: An analysis of the PPMI data , 2019, Autonomic Neuroscience.

[17]  Kelly A. Mills,et al.  Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease. , 2018, Parkinsonism & related disorders.

[18]  C. S. Hubbard,et al.  Microstructural White Matter Abnormalities in the Dorsal Cingulum of Adolescents with IBS , 2018, eNeuro.

[19]  G. Deuschl,et al.  Pallidal dopaminergic denervation and rest tremor in early Parkinson's disease: PPMI cohort analysis. , 2018, Parkinsonism & related disorders.

[20]  E. Pekkonen,et al.  More than constipation – bowel symptoms in Parkinson's disease and their connection to gut microbiota , 2017, European journal of neurology.

[21]  J. Fukae,et al.  The Prevalence of Constipation and Irritable Bowel Syndrome in Parkinson’s Disease Patients According to Rome III Diagnostic Criteria , 2017, Journal of Parkinson's disease.

[22]  T. Di Paolo,et al.  Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments , 2016, Parkinson's disease.

[23]  Jacques Darcourt,et al.  Implementation of the European multicentre database of healthy controls for [123I]FP-CIT SPECT increases diagnostic accuracy in patients with clinically uncertain parkinsonian syndromes , 2016, European Journal of Nuclear Medicine and Molecular Imaging.

[24]  B. Bonaz,et al.  Brain-gut-microbiota axis in Parkinson's disease. , 2015, World journal of gastroenterology.

[25]  K. Tominaga,et al.  Regional brain disorders of serotonin neurotransmission are associated with functional dyspepsia. , 2015, Life sciences.

[26]  T. Noponen,et al.  Differences in striatal dopamine transporter density between tremor dominant and non-tremor Parkinson’s disease , 2014, European Journal of Nuclear Medicine and Molecular Imaging.

[27]  F. Sung,et al.  Irritable bowel syndrome correlates with increased risk of Parkinson’s disease in Taiwan , 2014, European Journal of Epidemiology.

[28]  H. Reichmann,et al.  Sleep and non-motor symptoms in Parkinson’s disease , 2013, Journal of Neural Transmission.

[29]  S. Cheon,et al.  Nonmotor symptoms more closely related to Parkinson's disease: Comparison with normal elderly , 2013, Journal of the Neurological Sciences.

[30]  V. Voon,et al.  Impulse control disorders and depression in Finnish patients with Parkinson's disease. , 2012, Parkinsonism & related disorders.

[31]  K. Krogh.  Gastrointestinal Dysfunction in Parkinson’s Disease , 2011 .

[32]  A. Kishore,et al.  Do nonmotor symptoms in Parkinson's disease differ from normal aging? , 2011, Movement disorders : official journal of the Movement Disorder Society.

[33]  G. Knudsen,et al.  Serotonin Transporters in Dopamine Transporter Imaging: A Head-to-Head Comparison of Dopamine Transporter SPECT Radioligands 123I-FP-CIT and 123I-PE2I , 2010, The Journal of Nuclear Medicine.

[34]  H. Vankova.  Mini Mental State , 2010 .

[35]  H. Shill,et al.  Multi-organ distribution of phosphorylated α-synuclein histopathology in subjects with Lewy body disorders , 2010, Acta Neuropathologica.

[36]  J. Jankovic,et al.  Movement Disorder Society‐sponsored revision of the Unified Parkinson's Disease Rating Scale (MDS‐UPDRS): Scale presentation and clinimetric testing results , 2008, Movement disorders : official journal of the Movement Disorder Society.

[37]  Alan A. Wilson,et al.  Elevated serotonin transporter binding in depressed patients with Parkinson's disease: A preliminary PET study with [11C]DASB , 2008, Movement disorders : official journal of the Movement Disorder Society.

[38]  D. Drossman,et al.  Rome III: New standard for functional gastrointestinal disorders. , 2006, Journal of gastrointestinal and liver diseases : JGLD.

[39]  K. Chaudhuri,et al.  Non-motor symptoms of Parkinson's disease: diagnosis and management , 2006, The Lancet Neurology.

[40]  K. Ray Chaudhuri,et al.  The non-motor symptom complex of Parkinson’s disease: A comprehensive assessment is essential , 2005, Current neurology and neuroscience reports.

[41]  G. Rees.  Statistical Parametric Mapping , 2004, Practical Neurology.

[42]  E. David Williams,et al.  The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease , 2004, NeuroImage.

[43]  Johan Marinus,et al.  Assessment of autonomic dysfunction in Parkinson's disease: The SCOPA‐AUT , 2004, Movement disorders : official journal of the Movement Disorder Society.

[44]  W. Pirker,et al.  Correlation of dopamine transporter imaging with parkinsonian motor handicap: How close is it? , 2003, Movement disorders : official journal of the Movement Disorder Society.

[45]  V. Dhawan,et al.  Parametric mapping of [18F]FPCIT binding in early stage Parkinson's disease: A PET study , 2002, Synapse.

[46]  C. Tanner,et al.  Frequency of bowel movements and the future risk of Parkinson’s disease , 2001, Neurology.

[47]  Karl J. Friston,et al.  Statistical parametric mapping with 18F-dopa PET shows bilaterally reduced striatal and nigral dopaminergic function in early Parkinson’s disease , 1999, Journal of neurology, neurosurgery, and psychiatry.

[48]  P B Hoffer,et al.  SPECT imaging of dopamine transporters in human brain with iodine-123-fluoroalkyl analogs of beta-CIT. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.

[49]  S. Wexner,et al.  A constipation scoring system to simplify evaluation and management of constipated patients , 1996, Diseases of the colon and rectum.

[50]  S. Folstein,et al.  “Mini-mental state”: A practical method for grading the cognitive state of patients for the clinician , 1975 .

[51]  P. Dupont,et al.  Insula activity to visceral stimulation and endocrine stress responses as associated with alexithymia in patients with irritable bowel syndrome. , 2019, Psychosomatic medicine.

[52]  R. Pfeiffer.  Non-motor symptoms in Parkinson's disease. , 2016, Parkinsonism & related disorders.

[53]  A. Zinsmeister,et al.  FUNCTIONAL BOWEL DISORDERS , 2007, The American Journal of Gastroenterology.

[54]  A. Dawson.  The irritable bowel. , 1984, The Practitioner.

[55]  W. Gibb,et al.  Occasional Review , 2022 .